• The IBS-IBD Connection?

    Original Date: March 15, 2014
    Presenter: Steven Sandberg-Lewis, ND, DHANP


    As well educated physicians, we understand that IBS is a functional disorder and that IBD is an autoimmune pathology and never the two shall meet. Dr. Steven Sandberg-Lewis will differentiate these two conditions, contrasting when they differ and illustrating when and how they can coincide in pne patient. He will present research findings, which over the last 7 years has shed light on the overlapping of these diseases. This knowledge may help us diagnose them more intelligently and treat them both more effectively. Learn about lymphocytic colitis (a lesser known microscopic form of IBD) as well as time proven natural therapies for Crohn disease and ulcerative colitis.

    Learning objectives:

    • Participants will understand the emerging role of inflammation in IBS and how this compares to the inflammation in IBD
    • Participants will grasp the details of lymphocytic colitis – a less known form of microscopic colitis
    • Participants will learn the evidence-based natural treatments for IBD

    2 general CEUs for NDs approved by OBNM
  • Research Updates on Celiac Disease and Non-Celiac Gluten Sensitivity


    Original Date: March 15, 2014
    Presenter: Lisa Shaver, ND, LAc

    The lecture offers updates on celiac disease and non-celiac gluten sensitivity (NCGS). The symptom picture of a celiac shifts drastically from one patient to the next, creating a challenging model for the physician. Dr Shaver discusses diagnostic options, pertinent follow-up time lines, concomitant disease processes implicated in celiac disease, correlative disease risks beyond the GI tract and practical naturopathic treatment options. Dr Shaver presents the latest research updates on celiac disease and NCGS.

    1.5 general CEUs for NDs approved by OBNM
  • Effective Treatments for Clostridium difficile Colitis

    Original Date: March 15, 2014
    Presenter: Mark Davis, ND

    Clostridium difficile infection (CDI) affects # people and causes over 14,000 annual deaths in the United States per year. For the past decade, this condition has been more frequent, severe, refractory to standard therapy, and likely to relapse than previously described. This presentation covers pharmaceutical, botanical, biotherapeutic and other interventions for CDI.

    1.5 general CEUs for NDs approved by OBNM


  • Updates in Naturopathic Proctology

    Original Date: March 15, 2014
    Presenter: Steve Gardner, ND

    NCNM is proud to feature faculty member Steven L. Gardner DC, ND, who closes Saturday's presentations with an update of conditions and treatments of the anorectal canal and gastrointestinal tract. Dr. Gardner brings over 30 years of clinical experience of treating hemorrhoids, fissures, fistulae, pruritis and chronic constipation. He will present current treatment solutions for these pathologies. Case histories and photo images of treatment protocols will be presented, including minor surgical techniques. Patient history and regional examination will be emphasized. Dr Gardner will also discuss current antibiotic choices for the acute abscess.

    1.5 general CEUs for NDs approved by OBNM
  • Non-Alcoholic Steatohepatitis, Cannabanoid Hyperemesis and Pancreatitis

    Original Date: March 16, 2014
    Presenter: Mona Morstein, ND

    Dr. Morstein starts our Sunday morning with a discussion of common and not so common gastroenterological conditions. Non-alcoholic fatty liver disease is the most common chronic liver condition in the US, and is associated with many etiological factors, but the main one is being overweight/obese. Learning about this condition, how to diagnose and treat is important, as it is reversible; and if not reversed, patients have the risk of developing fibrosis and cirrhosis of the liver. Pancreatitis, acute in particular, can walk in your door any day. Learning the alarm signs of instant referral to the Emergency Department is important, but 80% of patients with acute pancreatitis can be treated safely and effectively at home by an ND, doing proper care.

    Chronic pancreatitis treatment is designed to preserve remaining pancreas functioning and allow absorption of nutrients. Cannaboid Hyperemesis is oftentimes an extremely intense gastrointestinal condition due to chronic use of marijuana. With Medical Laws and legal use of pot increasing in states, NDs must be able to identify this condition and give patients the knowledge they need to prevent its recurrence.

    2 general CEUs for NDs approved by OBNM


  • The Gut-Brain Axis in Autoimmune and Neuroimmune Disorders

    Original Date: March 16, 2014
    Presenter: Aristo Vojdani, PhD


    The human body is an intricate system with bidirectional communication between organ that requires balance and harmony for optimal performance. The parallels between the gut and brain immune systems are self-evident. These similarities extend to the actual structures, mechanisms and even biochemistries of the two systems: the gut immune barrier (GIB) and the blood-brain barrier (BBB). The gut’s influence on the brain cannot be overestimated, so much so that it can be called a second brain.

    This presentation will review the link between gut dysbiosis, infections and inflammation to brain-related disorders such as depression, anxiety, multiple sclerosis and autism. By understanding the mechanisms of environmental triggers of gut dysfuctions that lead to autoimmunity or neurological disorders, it is possible to prevent, ameliorate and even reverse autoimmune disorders, both gastrointestinal and neurodegenerative, through treatment modalities involving the repair of the GIB and BBB, thus restoring the functionality of their barriers and the stability of their environments.

    Learning objectives:
    • To understand how the gut and brain are co-dependent parts of a complex immune system, interacting with and affecting each other’s functions.
    • To map the roles gut microbiota play in the gut-brain axis.
    • To identify environmental triggers that are either directly or by induction of oxidation or citrullination, contributing to gut barrier and blood-brain barrier dysfunction resulting in autoimmunities.
    1.5 general CEUs for NDs approved by OBNM
  • Advances in Understanding the Gut Flora

    Original Date: March 16, 2014
    Presenter: Eric Yarnell, ND

    Dr. Eric Yarnell will present a paradigm of gut flora “biotypes” that people might fall into. He will describe how special organisms are increasingly linked to specific diseases, such as:
    • Absence of Faecalibacterium prausnitzii and IBD
    • Role of gut flora in chronic renal failure
    • Oxalobacter formigenes and kidney stones
    • Uropathogen pool in the gut and how treating the gut might prevent UTIs
    • Role of gut flora in diabetes and obesity
    Dr. Yarnell will explain how adherent and luminal gut flora are different from each other. He will elucidate the role of niche microbes in small numbers vs. strict anaerobes in large numbers. He will contrast efficacy of dead versus living oral probiotic supplementation, as well as fermented food versus probiotic pills. He will expound on the role of glut flora in breast milk and how we end up with gut flora

    1.5 general CEUs for NDs approved by OBNM
  • This course requires an enrollment key
    Cost: US$ 52.50
    Helminthic Therapy

    Original Date: March 16, 2014
    Presenter: Mark Davis, ND


    Dr. Mark Davis will present a new range of potential treatment approaches for inflammatory bowel disease and other gastrointestinal disorders. Helminths are worm-like organisms that naturally live in and feed on about 1.5 billion human hosts around the world today. For most of medical history, helminths have been classified as parasites, but some of these organisms, such as Enterobius vermicularis (the common pinworm), may be commensal—benefiting from the human host without causing harm—and some others may actually be mutualistic—benefiting from the human host while conferring benefit upon the host. Dr. Davis will focus on these conditionally mutualistic organisms, which confer benefit on some human hosts but not on others, based on ancestry, environment, and epigenetics.

    1.5 general CEUs for NDs approved by OBNM